How an independent sponsor prices a deal before the money exists

I price private companies for a living, more than a thousand of them, and I have sat on the other side of enough capital raises to notice how independent sponsors talk about their deals. They describe the hard part as raising the money. It almost never is. The hard part happened weeks earlier, when they wrote a number on a letter of intent with no committed capital behind it.

A funded buyer prices a deal and then draws capital. An independent sponsor prices a deal and then has to sell that price to someone who was never in the room and whose alternative is simply to do nothing. That is a different problem. Here is how the structure works, what a half turn of overpayment costs a sponsor personally, and how to build a price that survives the second look.

The fastest-growing buyer in the lower middle market

Start with who these buyers are, because the category has grown faster than the language around it. An independent sponsor, sometimes still called a fundless sponsor, sources and signs an acquisition before raising the equity to pay for it. Instead of a committed fund, they assemble the capital deal by deal from family offices, SBIC funds, mezzanine lenders and institutional co-investors. Axial's 2025 Independent Sponsor Report put independent sponsors at 27 percent of closed deals on its platform over the trailing twelve months, the largest share of any buyer type, against 20 percent for traditional private equity funds. In the part of the market where founder-owned and family-owned companies actually change hands, the fundless buyer is now the median buyer.

Until recently there was no serious performance data on any of it, which made the category easy to dismiss. That changed in 2026. Gregory Brown and William M. Volckmann II of the Institute for Private Capital and UNC Kenan-Flagler analyzed 846 independent sponsor transactions and benchmarked them against matched United States buyouts up to $100 million of investment size. Independent sponsor deals returned a median gross IRR of 23.8 percent against 18.5 percent for the matched buyouts, at a median of 2.1 times invested capital. The sponsors were not amateurs: 88 percent had prior private equity experience and two thirds had completed three or more transactions.

Read the dispersion alongside the median, because that is what a capital provider is actually thinking about. Roughly 25 percent of those deals returned 4.0 times or more, about 5 percent were complete write-offs, and loss incidence ran 23.5 percent against 21.6 percent for the matched buyouts. The model outperforms on the median and loses slightly more often. That is exactly the shape you would expect from a buyer whose entry price is set under time pressure.

The price is the pitch, so it gets underwritten twice

Here is the structural asymmetry that nobody warns a first-time sponsor about. A committed fund underwrites a price once, internally, and the investment committee that approves it is the same institution that wires the money. An independent sponsor's price is underwritten twice. The first underwrite is their own, done fast, under exclusivity pressure, with the seller watching. The second underwrite is done weeks later by a capital provider who was not in the room, does not know the seller, has no sunk cost in the process, and can walk away at no reputational cost at all.

The two audiences want opposite things from the number. The seller wants the price high enough to sign. The capital provider wants it low enough to be obviously safe, because they are being asked to fund a number that someone else already committed to. A price set to win the seller is, by construction, a price the funder has to be talked into. That is where the slow responses and the reopened diligence come from. It is not a capital markets problem. It is a pricing problem that has been deferred.

So the discipline is unusual: price for the harder audience first, then find out whether the seller will take it. Getting that order backwards is the most expensive habit in the model.

Leverage is sized off EBITDA, so the last half turn is all equity

Now the mechanical part, which is where most of the damage happens quietly. Lenders do not size debt as a percentage of purchase price. They size it as a multiple of EBITDA, because EBITDA is what services the debt and the purchase price is somebody's opinion. The consequence is arithmetic and it is unforgiving: once the debt is sized, every additional dollar of price is funded entirely with equity.

Take an illustrative company earning $3 million of EBITDA, with a lender willing to advance 3.0 times, so $9 million of debt. At an entry multiple of 6.0 times, the price is $18 million and the equity check is $9 million. Concede half a turn and the price becomes $19.5 million, but the debt does not move, so the equity check becomes $10.5 million. An 8.3 percent increase in price produced a 16.7 percent increase in the equity the sponsor has to go and raise. The ask moves at roughly twice the rate of the concession.

This is why a sponsor who concedes on price in the room often finds the capital raise mysteriously harder afterwards. Nothing mysterious happened. They grew the thing they were selling to investors by twice the amount they thought they were giving away, at exactly the moment they lost the ability to change it.

What half a turn costs the sponsor personally

Follow that same illustrative deal to an exit and the cost lands somewhere more pointed: the sponsor's own promote. Carried interest does not sit on the whole gain. It sits behind a preferred return, and the preferred return compounds on the equity that was invested. Citrin Cooperman's 2025 Independent Sponsor Report, which drew on more than 170 professionals in the sector, found the most typical hurdle rate is 8 to 9.9 percent, reported by 63 percent of respondents, and that 74 percent use a full catch-up.

Say the company exits in year five with EBITDA grown to $4.5 million at a 7.0 times multiple, so $31.5 million of enterprise value, with debt paid down to $3 million. That leaves $28.5 million of equity proceeds in both cases, because the exit has nothing to do with what was paid at entry. An 8 percent preferred return compounds to about 1.47 times over five years. On the $9 million entry, the hurdle is $13.2 million and the profit above it is $15.3 million. On the $10.5 million entry, the hurdle is $15.4 million and the profit above it is $13.1 million. At a 20 percent promote, that is $3.06 million of carry against $2.61 million: a $441,000 difference on a $1.5 million concession, or about 29 cents of the sponsor's own money for every dollar given away at the table. It costs more than the concession proportionally because the extra equity compounds the hurdle too.

A tiered structure makes it worse rather than better. The equity multiple in that example falls from 3.17 times to 2.71 times, which in a typical stepped waterfall can drop the sponsor out of a higher carry tier entirely rather than merely shrinking the base it applies to. And tiered structures are now the norm: Citrin Cooperman found multiple on invested capital is the hurdle basis for 50 percent of respondents, up from 27 percent in 2019, while IRR has fallen to 20 percent. A sponsor negotiating MOIC tiers has agreed, whether they thought about it this way or not, that the entry multiple is the single largest determinant of their personal compensation.

The fee stack is real money, and it points the wrong way

Sponsor economics have genuinely standardized, which is worth knowing before any negotiation. From the same Citrin Cooperman report: 82 percent now calculate the closing fee as a percentage of transaction value, and 56 percent of those use 2 percent. Only 3 percent of sponsors forgo a closing fee at all, down from 9 percent in 2017. Annual management fees are most often a percentage of EBITDA with a floor and a cap, reported by 51 percent, and 69 percent of those use 5 percent of EBITDA, up from 49 percent in 2019. On carry, 64 percent now reach a maximum of 25 percent or more, against 37 percent in 2019.

Now put the fee stack next to the promote and notice which way each one points. On the illustrative deal above, a 2 percent closing fee is $360,000 at an $18 million price and $390,000 at $19.5 million. Paying $1.5 million more earns the sponsor $30,000 of extra closing fee and costs them $441,000 of promote. The one component of sponsor compensation that rewards a higher price is roughly a fourteenth of the size of the component that punishes it. The fees pay for the search. The promote is the business. Any sponsor whose pricing instincts are being shaped by closing-fee arithmetic is optimizing the small number at the expense of the large one.

The capital provider is underwriting you, not the company

A capital provider can see the company perfectly well. They get the same financials, they can commission their own quality of earnings work, and often they know the sector better than the sponsor does. What they cannot see is whether this particular sponsor habitually pays the top of the band.

That is what the dispersion in the Institute for Private Capital data is really telling you. When a quarter of deals return 4.0 times or more and roughly one in twenty is a total loss, the discipline of the sponsor is doing a lot of the work, which is presumably why 88 percent of that sample had prior private equity experience. A funder is pricing your judgment across deals, using this deal as the evidence. A sponsor who arrives with a single number and a narrative is asking to be taken on faith. A sponsor who arrives with a range, a stated position inside it, and a list of what would move them is handing the funder a way to check the work.

How to price a deal you have not funded yet

The method is not complicated. Start with a band and a sample size, never a point estimate. In my own Felpel Private Company Index, across 7,601 transactions the median cleared 2.67 times seller's discretionary earnings with the middle half between 2.0x and 3.4x. That dataset is online and asset-light, and 98 percent of it sits under $5 million of enterprise value, so those multiples are not the sponsor's size band and are not comparables for a $20 million deal. The transferable finding is the shape, not the level: the interquartile range in any honest transaction sample is wide enough to swallow the whole argument you are having about price.

Anchor on cleared prices, never on asks. In the same index, active listings ask about 3.26x SDE while verified-sold deals clear at about 2.58x on a paired sample of 2,820 transactions. Stated one way the ask carries roughly a 26 percent premium; stated the other way the clearing price sits roughly 21 percent below the ask. Both framings come from the same two numbers, so it is worth saying which arithmetic you mean. Either way, a comp set built from listings runs high, and listings are what is freely available precisely because the organizations publishing them monetize listings.

Then price for the second underwrite. Work out the entry multiple at which the deal still clears the preferred return comfortably, and treat that as the real ceiling rather than the price the seller might accept. Write the downside price before the offer price, because writing it afterwards is rationalization. Price the structure alongside the multiple: the IBBA and M&A Source Market Pulse for the second quarter of 2026 reported sellers receiving 83 to 92 percent cash at close, so a headline multiple with a quarter of the consideration in a seller note is not the same deal as a lower one in cash. And name the half turn in both directions: what evidence would justify paying more, and what finding would force you down. That list is what makes a price defensible to somebody who was not there.

The independent sponsor model works, and the first serious dataset on it now says so. But it works on a narrower margin for error than a committed fund enjoys, because the price is set before the capital, judged twice, and funded entirely with equity at the margin. A sponsor who treats pricing as the thing that happens before the real work has the sequence exactly inverted. The price is the work. Everything after it is administration.

Common questions

What is an independent sponsor?

An independent sponsor, sometimes called a fundless sponsor, is a buyer who sources and signs an acquisition before raising the equity to pay for it. Instead of drawing on a committed fund, they take each deal to capital providers one at a time: family offices, SBIC funds, mezzanine lenders and institutional co-investors. They are now the largest single buyer type in the lower middle market. Axial's 2025 Independent Sponsor Report put independent sponsors at 27 percent of closed deals on its platform over the trailing twelve months, against 20 percent for traditional private equity funds.

How do independent sponsors get paid?

Through three components. A closing fee at the transaction, an annual management fee, and carried interest on the gain. Citrin Cooperman's 2025 Independent Sponsor Report, which drew on more than 170 professionals in the sector, found that 82 percent of respondents calculate the closing fee as a percentage of transaction value, and 56 percent of those use 2 percent. Annual management fees are most often a percentage of EBITDA with a floor and a cap, reported by 51 percent, and 69 percent of those use 5 percent of EBITDA. Carried interest is the most negotiated piece: minimum carry sits in the 10 to 25 percent range, and 64 percent of respondents now reach a maximum of 25 percent or more.

How is an independent sponsor different from a search fund?

The capital arrives at a different point and the job after closing is different. A search fund raises a small pool of search capital up front from a committed investor group, spends a defined period looking, buys one company, and the searcher usually becomes its full-time chief executive. An independent sponsor typically raises nothing up front, funds the search out of pocket or out of prior fees, sources the deal first, and raises the equity per transaction. Sponsors also tend to own from a board seat and hire an operator rather than run the business themselves, and many do it repeatedly rather than once.

Do independent sponsor deals actually perform?

The first large-scale evidence says yes, with a wide spread. A 2026 study by Gregory Brown and William M. Volckmann II of the Institute for Private Capital and UNC Kenan-Flagler analyzed 846 independent sponsor transactions and benchmarked them against matched United States buyouts up to $100 million of investment size. Independent sponsor deals returned a median gross IRR of 23.8 percent against 18.5 percent for the matched buyouts, at a median of 2.1 times invested capital. The dispersion is the important part: roughly 25 percent of deals returned 4.0 times or more while about 5 percent were complete write-offs, and loss incidence was 23.5 percent against 21.6 percent for matched buyouts.

How should an independent sponsor price a deal before raising the equity?

Price a range, not a number, and price it for the second underwrite rather than the first. Because lenders size debt off EBITDA rather than off purchase price, every incremental turn of price is funded almost entirely with equity, so the equity check moves roughly twice as fast as the price does. Work out the entry multiple at which the deal still clears the preferred return, write down the downside price before the offer price, list what evidence would move you half a turn in either direction, and bring the capital provider the range and the reasoning rather than a single number they have to take on faith.

Related reading

• Is a business worth 3x profit? The honest answer is a range.
• Quality of earnings: the report that moves the price.
• What acquirers really pay for when they buy your company.
• How I price a company in 48 hours.

Go deeper

If you are sitting on a live deal and you want a second opinion on the price before it goes to capital providers, let's work the range and the downside case together, or read more of how I think about pricing private companies.

Tomasz Felpel is an investor, founder, and advisor in private markets and healthcare, based in New York. He is a three-time founder of Value Alpha, an AI-powered private-markets valuation platform, Sonnerie VC, an early-stage healthcare venture firm, and Pond. Previously he led corporate development and M&A at Fortune 500 scale, pricing more than 1,000 private companies. Columbia Business School EMBA. Read the full story.